Temporary Pure Red-Cell Aplasia During Valproate Monotherapy: Clinical Observations and Spectral Electroencephalographic Aspects

Abstract

We report the case of a 4-year-old boy with pure red-cell aplasia associated with sodium valproate monotherapy. Treatment with valproate was initiated because of idiopathic tonic-clonic seizures; he became free of seizures. During the introduction of and ongoing antiepileptic drug treatment, clinical and laboratory controls using electroencephalographic (EEG) spectral analysis were performed at regular intervals and disclosed normal values. Ten months after the introduction of valproate, clinical examination was normal except for marked pallor. Peripheral blood showed macrocytic anemia and the bone marrow finding was isolated absolute erythroblastopenia. At the same time, significant changes in EEG background activity were present as well-defined slowing. There was an increase in the relative power of theta activity and a decrease in alpha 2 activity in the occipital regions. Valproate was discontinued and phenobarbital therapy introduced. A complete resolution of the hematologic damage was observed after valproate withdrawal. Recovery of the hematologic parameters started 14 days after discontinuation of valproate therapy, while normalization of EEG background activity was observed earlier. The patient maintained stable hematologic values and seizure control without disturbances of the spectral EEG. After 6 months of phenobarbital therapy, re-administration of sodium valproate was not followed by recurrence of any clinical or electrophysiologic symptoms or abnormalities. (J Child Neurol 2000;15:485-487).

Get full access to this article

View all access options for this article.

References

MacDougall LG : Pure red cell aplasia associated with sodium valproate therapy. JAMA 1982;247:53-54.

Stahl Mms , Neiderud J. , Vinge E. : Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid. J Pediatr 1997 ;130:1001-1003.

Zeller JA , Schlesinger S. , Runge U. , Kessler C. : Influence of valproate monotherapy on platelet activation and hematologic values. Epilepsia 1999;40:186-189.

Brichard B. , Vermylen C. , Scheiff J.M. , et al: Haematological disturbances during long-term valproate therapy . Eur J Pediatr 1994;153: 378-380.

Ganick D.J. , Sunder T. , Finley J. : Severe hematologic toxicity of valproic acid. A report of four cases . Am J Hematol Oncol 1990;12:80-85.

Benninger C. , Matthis P. , Scheffner D. : Spectral analysis of the EEG in children during the introduction of antiepileptic therapy with valproic acid. Neuropsychobiology 1985;13:93-96.

Benninger C. , Matthis P. , Scheffner D. : EEG development of healthy boys and girls. Results of a longitudinal study. Electroencephalogr Clin Neurophysiol 1984;57:1-12.

Symon Dnk , Russel G. : Sodium valproate and neutropenia. Arch Dis Child 1983;58:235.

Rajantie J. , Kajosaari M. , Ylitalo V. : Fatal pancytopenia during high-dose valproate monotherapy. Eur J Pediatr 1992;151:619-620.

10.

Watts RG , Emanuel PD , Zuckerman KS , Howard TH : Valproic acid-induced cytopenias: Evidence for a dose-related suppression of hematopoiesis. J Pediatr 1990;117:495-199.